ImageneBio, Inc. Other Current Liabilities
ImageneBio, Inc. (IMA) had Other Current Liabilities of $250.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Current $250.00K.
- 2026-03-31: Other Liabilities, Current $316.00K.
- 2025-12-31: Other Liabilities, Current $164.00K.
- 2025-06-30: Other Liabilities, Current $39.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $250.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $316.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $164.00K 10-Q · filed 2026-08-05 |
| 2025-06-30 | $39.00K 10-Q · filed 2025-07-24 |
| 2025-03-31 | $140.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $23.00K 10-Q · filed 2025-07-24 |
| 2024-09-30 | $47.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $69.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $46.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $85.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $459.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $10.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $14.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $119.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $30.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $243.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $16.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $26.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $13.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $11.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $168.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $380.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |